Company Thermo Fisher Scientific Inc.
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
529.36 USD | +1.63% | -0.05% | -0.27% |
Business description: Thermo Fisher Scientific Inc.
- laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.;
- diagnostics equipment and products (15.3%);
- scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc.
Net sales break down by source of income into products sales (78.5%) and services (21.5%).
Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Number of employees: 122,000
Sales by Activity: Thermo Fisher Scientific Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Laboratory Products and Biopharma Services | 10.6B | 12.24B | 14.86B | 22.51B | 23.04B |
Analytical Instruments | 5.52B | 5.12B | 6.07B | 6.62B | 7.26B |
Life Sciences Solutions | 6.86B | 12.17B | 15.63B | 13.53B | 9.98B |
Specialty Diagnostics | 3.72B | 5.34B | 5.66B | 4.76B | 4.4B |
Eliminations | -1.15B | -2.66B | -3.01B | -2.52B | -1.83B |
Geographical breakdown of sales: Thermo Fisher Scientific Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
United States | 12.37B | 16.44B | 18.91B | 23.82B | 22.01B |
Others | 10.42B | 12.99B | 16.86B | 17.3B | 20.84B |
China | 2.75B | 2.8B | 3.44B | 3.79B | - |
Managers: Thermo Fisher Scientific Inc.
Director | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 2009-10-14 |
Director of Finance/CFO | 57 | 2015-07-31 | |
Sebastian Pacios
CTO | Chief Tech/Sci/R&D Officer | - | 2023-09-30 |
Alan Sachs
CTO | Chief Tech/Sci/R&D Officer | - | 2015-12-31 |
Michel Lagarde
COO | Chief Operating Officer | 50 | 2021-12-31 |
Members of the board: Thermo Fisher Scientific Inc.
Manager | Title | Age | Since |
---|---|---|---|
Scott Sperling
BRD | Director/Board Member | 66 | 2006-11-08 |
Marc Casper
CHM | Chairman | 56 | 2020-02-25 |
Tyler Jacks
BRD | Director/Board Member | 63 | 2009-05-25 |
Nelson Chai
BRD | Director/Board Member | 58 | 2010-12-09 |
C. Harris
BRD | Director/Board Member | 67 | 2012-03-29 |
Dion Weisler
BRD | Director/Board Member | 56 | 2017-02-28 |
James Mullen
BRD | Director/Board Member | 65 | 2018-11-06 |
Debora Spar
BRD | Director/Board Member | 60 | 2019-09-04 |
R. Keith
BRD | Director/Board Member | 56 | 2020-11-19 |
Ruby Chandy
BRD | Director/Board Member | 62 | 2022-02-28 |
Holdings: Thermo Fisher Scientific Inc.
Name | Equities | % | Valuation |
---|---|---|---|
AIFORIA TECHNOLOGIES OYJ 6.78% | 1,959,200 | 6.78% | 7,470,194 $ |
Company details: Thermo Fisher Scientific Inc.
Thermo Fisher Scientific, Inc.
168 Third Avenue
02451, Waltham
+781 622 1000
http://www.thermofisher.comGroup companies: Thermo Fisher Scientific Inc.
Name | Category and Sector |
---|---|
FEI Trondheim AS
| |
Fisher Scientific the Hague V BV
Fisher Scientific the Hague V BV Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Fisher Scientific the Hague V BV provides management services. The company is based in Breda, Netherlands. |
Miscellaneous Commercial Services
|
Fisher Scientific SAS
Fisher Scientific SAS Wholesale DistributorsDistribution Services Fisher Scientific SAS develops and manufactures laboratory equipment. Its products includes analytical instruments, pumps, quality control tests, software, consumables, and reagents. The company is headquartered in Illkirch Graffenstaden, France. |
Wholesale Distributors
|
FEI Europe BV
| |
Thermo Fisher Scientific (Finance I) BV
Thermo Fisher Scientific (Finance I) BV Finance/Rental/LeasingFinance Part of Thermo Fisher Scientific, Inc., Thermo Fisher Scientific (Finance I) BV functions as a financing subsidiary/special purpose entity. The company is based in Breda, Netherlands. |
Finance/Rental/Leasing
|
Other Advanced Medical Equipment & Technology
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+1.63% | -0.05% | +8.08% | -17.05% | 202B | ||
+0.50% | +1.55% | +77.31% | +61.51% | 196B | ||
+0.99% | -3.99% | +5.81% | -27.69% | 166B | ||
-0.51% | -0.65% | +63.91% | +116.20% | 133B | ||
-0.54% | +0.23% | -2.46% | -23.02% | 60.84B | ||
+3.06% | +0.89% | -11.21% | -25.95% | 43.72B | ||
-1.24% | +0.25% | +3.40% | -40.12% | 42.19B | ||
+1.97% | +1.89% | +10.52% | -10.06% | 40.09B | ||
-0.40% | -2.38% | +18.56% | - | 37.12B | ||
+0.84% | -3.06% | +48.22% | -9.93% | 35.43B | ||
Average | +0.64% | -0.64% | +22.21% | +2.65% | 95.69B | |
Weighted average by Cap. | +0.71% | -0.58% | +29.85% | +15.71% |
Sector
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMO Stock
- Company Thermo Fisher Scientific Inc.